The China Mail - Who should get paid for nature's sequenced genes?

USD -
AED 3.672498
AFN 63.500465
ALL 83.283733
AMD 367.003219
ANG 1.790403
AOA 917.000184
ARS 1471.035205
AUD 1.449338
AWG 1.80125
AZN 1.689175
BAM 1.724577
BBD 2.013888
BDT 122.992813
BGN 1.69088
BHD 0.377147
BIF 2984.81535
BMD 1
BND 1.298984
BOB 6.909809
BRL 5.201836
BSD 0.999934
BTN 94.624111
BWP 13.680173
BYN 2.818068
BYR 19600
BZD 2.01104
CAD 1.423225
CDF 2268.99975
CHF 0.81263
CLF 0.023263
CLP 915.590329
CNY 6.790496
CNH 6.81352
COP 3428.35
CRC 455.186766
CUC 1
CUP 26.5
CVE 97.22259
CZK 21.37625
DJF 178.061717
DKK 6.592015
DOP 58.613453
DZD 133.528416
EGP 49.636698
ERN 15
ETB 161.211774
EUR 0.88182
FJD 2.24825
FKP 0.758197
GBP 0.759805
GEL 2.645016
GGP 0.758197
GHS 11.199781
GIP 0.758197
GMD 72.49805
GNF 8761.518452
GTQ 7.627362
GYD 209.162776
HKD 7.840295
HNL 26.755726
HRK 6.640898
HTG 130.744947
HUF 314.087979
IDR 17976
ILS 2.984749
IMP 0.758197
INR 94.412
IQD 1309.878094
IRR 1375049.999798
ISK 126.810208
JEP 0.758197
JMD 157.488647
JOD 0.708978
JPY 161.677495
KES 129.590162
KGS 87.449821
KHR 4017.494974
KMF 430.999856
KPW 900.00035
KRW 1546.34502
KWD 0.30947
KYD 0.833297
KZT 486.623047
LAK 21948.961236
LBP 89556.012134
LKR 337.341005
LRD 182.134827
LSL 16.623945
LTL 2.95274
LVL 0.60489
LYD 6.430933
MAD 9.401479
MDL 17.709096
MGA 4177.101337
MKD 54.353625
MMK 2099.539901
MNT 3580.066416
MOP 8.076099
MRU 39.982188
MUR 48.209966
MVR 15.45971
MWK 1733.881812
MXN 17.6195
MYR 4.137977
MZN 63.902143
NAD 16.623945
NGN 1372.679674
NIO 36.797319
NOK 9.83835
NPR 151.394749
NZD 1.772154
OMR 0.384501
PAB 0.999965
PEN 3.391297
PGK 4.386951
PHP 61.5525
PKR 278.100478
PLN 3.78105
PYG 6099.351442
QAR 3.635217
RON 4.618803
RSD 103.50701
RUB 74.893431
RWF 1468.89467
SAR 3.754889
SBD 8.065041
SCR 13.65272
SDG 600.499082
SEK 9.77475
SGD 1.29826
SHP 0.746601
SLE 24.750204
SLL 20969.503664
SOS 571.478959
SRD 37.482989
STD 20697.981008
STN 21.603509
SVC 8.749173
SYP 110.532098
SZL 16.621989
THB 33.430499
TJS 9.284423
TMT 3.51
TND 2.972467
TOP 2.40776
TRY 46.49775
TTD 6.780184
TWD 31.733017
TZS 2620.502978
UAH 44.88455
UGX 3689.350352
UYU 39.918699
UZS 12024.108178
VES 616.865275
VND 26335
VUV 118.798432
WST 2.761642
XAF 578.424923
XAG 0.016838
XAU 0.000248
XCD 2.70255
XCG 1.802141
XDR 0.716966
XOF 578.417273
XPF 105.162912
YER 238.649503
ZAR 16.61355
ZMK 9001.202706
ZMW 18.024056
ZWL 321.999592
  • CMSD

    0.0300

    21.99

    +0.14%

  • BCC

    4.2100

    76.01

    +5.54%

  • GSK

    -0.8500

    51.22

    -1.66%

  • NGG

    0.5200

    82.09

    +0.63%

  • RBGPF

    0.9600

    61.3

    +1.57%

  • CMSC

    0.0650

    22.175

    +0.29%

  • AZN

    1.9800

    183

    +1.08%

  • RYCEF

    -0.4700

    18.16

    -2.59%

  • RELX

    0.1500

    31.36

    +0.48%

  • RIO

    -1.5700

    94.01

    -1.67%

  • JRI

    0.0050

    12.635

    +0.04%

  • VOD

    -0.1750

    13.875

    -1.26%

  • BP

    -1.2900

    38.04

    -3.39%

  • BCE

    0.0000

    23.04

    0%

  • BTI

    0.9250

    61.665

    +1.5%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: © AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

Y.Su--ThChM